AMZN
Amazon.com, Inc.
AMZN has the edge over TRS overall, supported by stronger fundamentals and stronger modeled upside.
TRS
TriMas Corporation
TRS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
TRS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Under pressure | |
| Strong |
TRS's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
TRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.6x | $37.62 | — |
| Cheap | 12x | $286 | +661% |
| Forward | 19x | $37.62 | — |
| Fair | 21x | $504 | +1238% |
| Expensive | 33x | $795 | +2012% |
Historical ranges are pointers, not guarantees.
TRS has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over TRS on the outlook, with more favorable revenue expectations.
TRS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect TRS's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over TRS on earnings, with more consistent year-over-year improvement.
TRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | -92% |
| Q2 2026 | $24.03 | +2541% |
| Q1 2026 | $24.07 | +3026% |
| Q4 2025 | $2.97 | +403% |
| Q3 2025 | $1.08 | +69% |
| Q2 2025 | $0.91 | -7.1% |
| Q1 2025 | $0.77 | -21% |
| Q4 2024 | $0.59 | -39% |
| Q3 2024 | $0.64 | -48% |
TRS earned $24.03 per share over the past year, more than ten times what it earned the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over TRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over TRS on profitability, with a higher operating margin.
TRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $174.6M | -36% |
| Q1 2026 | $168.3M | -30% |
| Q4 2025 | $155.5M | -32% |
| Q3 2025 | $269.3M | +17% |
| Q2 2025 | $274.8M | +14% |
| Q1 2025 | $241.7M | +6.4% |
| Q4 2024 | $228.1M | +8.8% |
| Q3 2024 | $229.4M | -2.5% |
TRS's revenue has slid since its 2025 peak: $175M last quarter, down 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 6.2% | -3.6 points |
| Q1 2026 | 4.1% | -4.9 points |
| Q4 2025 | -16% | -19 points |
| Q3 2025 | 6.2% | +2.6 points |
| Q2 2025 | 9.9% | +2.4 points |
| Q1 2025 | 9% | +3.5 points |
| Q4 2024 | 3.8% | -1.8 points |
| Q3 2024 | 3.6% | -6.5 points |
TRS's operating margin was 6.2% last quarter, down 3.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
TRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$45M | -440% |
| Q1 2026 | -$24.6M | -$20.9M |
| Q4 2025 | $36.8M | +204% |
| Q3 2025 | $22.8M | +125% |
| Q2 2025 | $13.2M | +76% |
| Q1 2025 | -$3.8M | +$13.2M |
| Q4 2024 | $12.1M | +6.7% |
| Q3 2024 | $10.2M | -52% |
TRS has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
TRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.2% | -1.2M shares |
| 1 year | -12% | -4.7M shares |
| 3 years | -13% | -5.4M shares |
| 5 years | -16% | -7.1M shares |
| Available history | -20% | -9.2M shares |
TRS has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $18.9M |
| Q1 2026 | $54.5M |
| Q4 2025 | $101.1M |
| Q3 2025 | — |
| Q2 2025 | $1.8M |
| Q1 2025 | $460,000 |
| Q4 2024 | — |
| Q3 2024 | $2.4M |
TRS spent $175M buying back its own shares over the past year, more than ten times what it spent the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -14.4x | Net Cash |
| Q1 2026 | -11.5x | Net Cash |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | 3.4x | Elevated |
| Q3 2024 | 3.6x | Elevated |
TRS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
TRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 27.0 | Neutral |
TRS's weekly RSI is 45 (neutral) and its Stochastic is 27 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
TRS PE vs Consumer Cyclical Sector
| Metric | TRS | Sector median | Relative |
|---|---|---|---|
| PE | 1.6x | 18x | 91% below |
| PE % | 0 | 47 | 47 pts below |
TRS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over TRS on trend strength, trading above more of its moving averages.
TRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 2.6% below |
| 20 week MA | $39.4 | 4.4% below |
| 50 week MA | $38.2 | 1.5% below |
| 100 week MA | $33.6 | 12% above |
| 200 week MA | $29.9 | 26% above |
TRS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 26% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over TRS on returns for 2026, with the stronger performance.
TRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.2 | $32.0 | +2.6% |
| 2021 | $32.0 | $34.8 | +8.5% |
| 2022 | $34.8 | $27.8 | -20% |
| 2023 | $27.8 | $25.3 | -8.7% |
| 2024 | $25.3 | $24.6 | -3% |
| 2025 | $24.6 | $36.1 | +47% |
| 2026 YTD | $36.1 | $37.6 | +4.1% |
TRS has finished lower in three of the last six years. It's up 4.1% so far in 2026.